European Commission is negotiating with Johnson and Johnson on pre-purchase of COVID-19 vaccine
A total of 27 EU national governments have authorised the use of an emergency fund of more than € 2 billion ($ 2,3 billion) for transactions with six vaccine manufacturers.
The pharmaceutical company Johnson and Johnson is on the list of these companies and the project is “under development“ said a senior health official from an EU member state, his identity was left anonymous as he asked. The European Commission has expressed a desire to reserve, and later make a preliminary purchase of the developed vaccine COVID-19. The company Johnson and Johnson, at the same time, reported that it was talking with many governments to make a vaccine against the virus, according to The Globe and Mail.
Johnson and Johnson is planning to trial on a human clinical vaccine from a contagious coronavirus next month, which has infected more than 8,36 million people worldwide.
Other European countries such as France, Italy, Germany, and the Netherlands announced last week that they had bought 400 million possible vaccines from British manufacturer AstraZeneca, a pharmaceutical company that is developing a coronavirus vaccine together with the University of Oxford. The company signed a similar deal in May with the United States.